Lithotripsy

Quanta System on the Peaks of the Urological Laser World Once Again: Quanta Magneto Technology™

Retrieved on: 
Friday, April 5, 2024
Health, Medical Devices, Surgery, General Health, Research, Science, Biotechnology, Quanta, Sorbonne University, Lithotripsy, Magneto, Holmium, History, Prostate, EAU, Surgeon, Safety, Cancer, Multimedia, Computer data storage

View the full release here: https://www.businesswire.com/news/home/20240404169544/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240404169544/en/
    Cyber Ho Magneto with Quanta Magneto Technology™ (Photo: Business Wire)
    On the way to its 40th anniversary Quanta System remains steadfast in its mission: innovate to improve the lives of people around the world; with an unwavering belief that progress is always possible.
  • The global leader in laser technologies continually collaborates with medical professionals, working side by side with doctors to advance healthcare.
  • It is this commitment that drives the latest groundbreaking addition to the Cyber Ho family: Cyber Ho Magneto.
  • Cyber Ho Magneto, in fact, is the first laser system that tamed the peak power of holmium, turning it into a much longer pulse duration providing the superior dusting of a Thulium Fiber Laser.

Olympus Announces FDA Clearance of RenaFlex™, Its First Single-use Flexible Ureteroscope

Retrieved on: 
Tuesday, April 2, 2024
System, U.S. FDA, Burns, Urology, Small Business Saturday, Lithotripsy, Endoscopy, Risk, Patient, Perforation, Infection, Health professional, Bleeding, Ureteroscopy, Kidney, Ureter, Urethra, Physician, Medical imaging

CENTER VALLEY, Pa., April 2, 2024 /PRNewswire/ -- Olympus, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, announced today U.S. FDA 510(k) clearance of its first single-use ureteroscope system, RenaFlex™, with full market availability to be announced at a later date.

Key Points: 
  • The RenaFlex single-use flexible ureteroscope system is used to access and visualize the urinary tract to diagnose and treat urinary diseases and disorders, such as kidney stones.
  • The RenaFlex ureteroscope can be used with endotherapeutic accessories to perform diagnostic and therapeutic procedures within the urinary tract.
  • The RenaFlex Single-use Ureteroscope works in combination with the compatible CV-S1 Video System Center for flexible Single-use Endoscopes.
  • Visit the urology product page for more information about the complete line of Olympus urology solutions.

EDAP Announces Third Quarter 2023 Financial Results

Retrieved on: 
Thursday, November 9, 2023
University of Zurich, AAGL, Hospital, EUR, USD, Overalls, Cleveland Clinic, International Symposium on Endovascular Therapy, Operating cost, EDT, Teaching hospital, University of Florida, Icahn School of Medicine at Mount Sinai, EDAP, League of European Research Universities, Prostate cancer, DACH, League, Marketing, Immunotherapy, University, Investment, Patient, TMS, Congress, Conference, Endo, Research, Growth, SEP, European Society of Gynaecological Oncology, Total, Poster, Lithotripsy, Mount Sinai Hospital, Randomized controlled trial, Pharmaceutical industry, Medical imaging, Film industry, Video game, Lithium, Medicine, Distribution, Urology

- Strong Q3 2023 U.S. Focal One® HIFU procedure growth of +150% year-over-year -

Key Points: 
  • - Strong Q3 2023 U.S. Focal One® HIFU procedure growth of +150% year-over-year -
    - Announces immunotherapy clinical research collaboration with Mount Sinai, Department of Urology -
    - Company to host conference call and webcast today, Thursday, November 9th at 8:30 am EDT -
    LYON, France, November 9, 2023 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies, reported today unaudited financial results for the third quarter ending September 30, 2023.
  • The decrease was driven by 1 Focal One system sold in the third quarter 2023 versus 3 systems sold in the third quarter of 2022.
  • Operating loss for the third quarter of 2023 was EUR 5.6 million (USD 6.0 million), compared to an operating loss of EUR 2.1 million (USD 2.2 million) in the third quarter of 2022.
  • A conference call and webcast to discuss the third quarter 2023 financial results will be hosted Ryan Rhodes, Chief Executive Officer, François Dietsch, Chief Financial Officer and Ken Mobeck, Chief Financial Officer of the U.S. subsidiary, today, Thursday, November 9th, 2023, at 8:30am EDT.

EDAP Announces Second Quarter 2023 Financial Results

Retrieved on: 
Thursday, August 24, 2023
Operating cost, University of Zurich, Assistant professor, CMS, University, AUC, Prostate cancer, TMS, Marketing, AUA, Medicines and Healthcare products Regulatory Agency, EDAP, League, American Urological Association, Woman, DACH, League of European Research Universities, USC, EDT, USD, Hospital, MD, Urology, Patient, Investment, Annual general meeting, High-intensity focused ultrasound, Growth, Lithotripsy, Conference, Cryptocurrency, Video game, Medical imaging, Pharmaceutical industry, Film industry, Lithium, EUR, Distribution

We are also pleased with strong U.S. Focal One HIFU procedure growth, which grew 85% during the second quarter of 2023 versus the second quarter of 2022.

Key Points: 
  • We are also pleased with strong U.S. Focal One HIFU procedure growth, which grew 85% during the second quarter of 2023 versus the second quarter of 2022.
  • The increase was driven by four Focal One units sold in the second quarter 2023 versus one unit sold in the second quarter of 2022.
  • Operating loss for the second quarter of 2023 was EUR 4.2 million (USD 4.6 million), compared to an operating loss of EUR 0.4 million (USD 0.5 million) in the second quarter of 2022.
  • A conference call and webcast to discuss second quarter 2023 financial results will be hosted Ryan Rhodes, Chief Executive Officer, François Dietsch, Chief Financial Officer and Ken Mobeck, Chief Financial Officer of the U.S. subsidiary, today, Thursday, August 24th, 2023 at 8:30am EDT.

Dataintelo releases comprehensive Global Mobile C-arm Systems Market report providing valuable insights and growth factors

Retrieved on: 
Wednesday, June 21, 2023
Telecom, Media monitoring service, Prevalence, Health professional, Conditional sentence, Da Vinci Surgical System, Research, 2600-series (CTA), Midsayap Diagnostic Center and Hospital, Google Play, Mobile advertising, TA Telecom, MMS, Government, Multimedia Messaging Service, Service provider, Diagnosis, Travel, SMS, Hospital, Cancer, Entertainment, Code, Mobile Money, Bleeding, Small and medium enterprises in Mexico, Research report, Wilford Hall Ambulatory Surgical Center, Financial services, Cardiac surgery, Segment, Mobile web, Small, Location, Peripheral, Hospital Insurance and Diagnostic Services Act, Patient, BFSI, Education, Dentistry, Medical device, Online shopping, Others, Health care, Lithotripsy, Automotive industry, Growth, Neurosurgery, Insurance

This research report is a comprehensive analysis of the market trends, growth factors, and opportunities in the mobile C-arm systems industry.

Key Points: 
  • This research report is a comprehensive analysis of the market trends, growth factors, and opportunities in the mobile C-arm systems industry.
  • The Global Mobile C-arm Systems Market report is a meticulously crafted document that offers a detailed analysis of the market based on type, application, end user, and region.
  • One of the standout features of the report is its focus on the growth factors driving the global mobile C-arm systems market.
  • The Global Mobile C-arm Systems Market report by Dataintelo is a valuable resource for anyone interested in the market dynamics, trends, and growth factors.

Dataintelo releases comprehensive Global Mobile C-arm Systems Market report providing valuable insights and growth factors

Retrieved on: 
Wednesday, June 21, 2023
Telecom, Media monitoring service, Prevalence, Health professional, Conditional sentence, Da Vinci Surgical System, Research, 2600-series (CTA), Midsayap Diagnostic Center and Hospital, Google Play, Mobile advertising, TA Telecom, MMS, Government, Multimedia Messaging Service, Service provider, Diagnosis, Travel, SMS, Hospital, Cancer, Entertainment, Code, Mobile Money, Bleeding, Small and medium enterprises in Mexico, Research report, Wilford Hall Ambulatory Surgical Center, Financial services, Cardiac surgery, Segment, Mobile web, Small, Location, Peripheral, Hospital Insurance and Diagnostic Services Act, Patient, BFSI, Education, Dentistry, Medical device, Online shopping, Others, Health care, Lithotripsy, Automotive industry, Growth, Neurosurgery, Insurance

This research report is a comprehensive analysis of the market trends, growth factors, and opportunities in the mobile C-arm systems industry.

Key Points: 
  • This research report is a comprehensive analysis of the market trends, growth factors, and opportunities in the mobile C-arm systems industry.
  • The Global Mobile C-arm Systems Market report is a meticulously crafted document that offers a detailed analysis of the market based on type, application, end user, and region.
  • One of the standout features of the report is its focus on the growth factors driving the global mobile C-arm systems market.
  • The Global Mobile C-arm Systems Market report by Dataintelo is a valuable resource for anyone interested in the market dynamics, trends, and growth factors.

MGG Investment Group Supports Investment in United Medical Systems

Retrieved on: 
Thursday, June 1, 2023
Professional Services, Business, Finance, UMS, Cataract, Warwick Investment Group, MGG, Hospital, Acquisition, Physician, Access, Growth, Integration, Lithotripsy, Urology, Nursing, Management, Cisco

MGG Investment Group LP (“MGG”) today announced that it has made a debt and equity investment to support Access & Integrated Practice Holdings’ acquisition of United Medical Systems Inc. (“UMS”), a national provider of premier transportable and in-house urology solutions to hospitals, surgery centers, and offices.

Key Points: 
  • MGG Investment Group LP (“MGG”) today announced that it has made a debt and equity investment to support Access & Integrated Practice Holdings’ acquisition of United Medical Systems Inc. (“UMS”), a national provider of premier transportable and in-house urology solutions to hospitals, surgery centers, and offices.
  • Partnering with physicians and medical facilities nationwide, UMS consistently delivers advanced technologies and cost-efficient solutions spanning MR/US fusion biopsies, lithotripsy, and laser lithotripsy.
  • Access & Integrated Practice Holdings is a comprehensive mobile medical services platform formed by MGG in 2022 following its investment in Sightpath Medical (“Sightpath”), a leading provider of mobile ophthalmic services for cataract and refractive surgery.
  • Kevin Griffin, Chief Executive Officer and Chief Investment Officer of MGG, said, “UMS has established a strong reputation in the medical community for integrity, patient focus, and clinical and operational excellence.

NextMed Provides Statement Regarding Unaffiliated Entity With Same Name in Wall Street Journal Article

Retrieved on: 
Wednesday, March 29, 2023
URL, The Wall Street Journal, Weight loss, Certification, Accreditation Commission for Health Care, Patient, Urology, ACHC, Lithotripsy, Cryptocurrency

NextMed wishes to clarify that it is not affiliated in any way with Helio Logistics, Next Medical, or the URL www.NextMed.com .

Key Points: 
  • NextMed wishes to clarify that it is not affiliated in any way with Helio Logistics, Next Medical, or the URL www.NextMed.com .
  • The companies mentioned in the Wall Street Journal article provide weight loss solutions.
  • NextMed is the only urology services provider in the United States with a comprehensive lithotripsy certification from the Accreditation Commission for Health Care (ACHC).
  • NextMed is committed to providing its integrated urology platform and lithotripsy services of the highest quality to all urologists, facilities and patients.

Matter Grows Health Portfolio by 65% YOY With Wins in Chronic Care, Real-World Evidence, Remote Patient Monitoring + More

Retrieved on: 
Tuesday, February 14, 2023
General Health, Social Media, Search Engine Optimization, Search Engine Marketing, Blogging, Health Technology, Other Communications, Publishing, Public Relations, Investor Relations, Marketing, Advertising, Communications, Health, Real-World Evidence, CO, Conditional sentence, Real world evidence, OR, Communication, Lithotripsy, Patient, IDD, Software, Clinical trial, Artificial intelligence, Disability studies, Lark Health, Merative, Spectrum, Chronic care, Growth, PR, Creativity, Multimedia, RWE, HRS, AVS, AI, Pharmaceutical industry, Health insurance, Autism spectrum

Jess re-joins the team after a three-year hiatus, during which she held executive leadership positions at IBM Watson Health and Lark Health.

Key Points: 
  • Jess re-joins the team after a three-year hiatus, during which she held executive leadership positions at IBM Watson Health and Lark Health.
  • Her well-rounded healthcare experience, bolstered by her direct forays into AI and Chronic Care, will help lead the practice into its next phase of growth.
  • Health Recovery Solutions (HRS) , a virtual care company that specializes in remote patient monitoring.
  • Matter has won 14 “Agency of the Year” accolades and has been consistently recognized as a top place to work .

Rhein Laser Launches UroFiber™ 1940nm 150W SuperPulsed Thulium Fiber Laser System

Retrieved on: 
Saturday, February 18, 2023
Prostate, Lithotripsy, Research, TFL, CW, BPH, Singing, Patient, Printed circuit board, Holmium

WUHAN, China, Feb. 18, 2023 /PRNewswire/ -- Rhein Laser Technologies Ltd., a leading manufacturer of innovative medical lasers for urologic, aesthetic and physiotherapy markets based in Wuhan and Dusseldorf, announces the launch of UroFiber™ 150Q which is the world's first 150W SuperPulsed thulium fiber laser (TFL) system, an innovative fiber laser technology for perfectly treating both stone lithotripsy and BPH enucleation.

Key Points: 
  • WUHAN, China, Feb. 18, 2023 /PRNewswire/ -- Rhein Laser Technologies Ltd., a leading manufacturer of innovative medical lasers for urologic, aesthetic and physiotherapy markets based in Wuhan and Dusseldorf, announces the launch of UroFiber™ 150Q which is the world's first 150W SuperPulsed thulium fiber laser (TFL) system, an innovative fiber laser technology for perfectly treating both stone lithotripsy and BPH enucleation.
  • Thulium laser may bring ground-breaking revolution in the field of laser lithotripsy.
  • Evidence shows that the thulium fiber laser enucleation of the prostate (ThuFLEP) is a highly efficacious, minimally invasive modality for the management of BPH in large volume glands (>80 cc).
  • UroFiber 150Q uses all-fiber technology with customized high-brightness narrow spectrum fiber-coupling 792nm diode laser pumping thulium fiber to achieve high power 1940nm CW&QCW laser.